ArticleBMC complementary medicine and therapies2026
Evaluation of the antibacterial and antifungal activity of 80% methanol crude extract and hexane, chloroform, butanol, and aqueous fractions of Suregada procera against selected microbial strains.
Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMedicinal plants are potential sources for developing novel antibiotics due to the declining effectiveness and associated side effects of synthetic drugs. This study aimed to evaluate the antibacterial and antifungal activities of 80% methanol crude extract and hexane, chloroform, butanol, and aqueous fractions of Suregada procera.
methodsThe dried roots of Suregada procera were macerated with 80% methanol and successively fractionated using hexane, chloroform, butanol, and aqueous solvents. The antibacterial and antifungal activities of both crude extract and the fractions were determined using agar well diffusion and broth dilution methods. One-way analysis of variance was used to analyze the data, followed by Tukey's post-hoc test. Ciprofloxacin 5 µg and amphotericin B 12.5 µg served as positive controls, while 1% dimethyl sulfoxide (DMSO) served as the negative control.
resultsThe Suregada procera crude extract exhibited the largest zone of inhibition (12.67 ± 0.33) against Staphylococcus epidermidis and Trichophyton mentagrophytes at 200 mg/mL. Among the six bacterial strains, Enterococcus faecalis was the most susceptible to hexane and aqueous fractions at 0.33 mg/mL. In contrast, the butanol fraction exhibited the highest inhibitory activity against Trichophyton mentagrophytes at 0.5 mg/mL.
conclusionThe results of the present study support the traditional use of Suregada procera against bacterial and fungal pathogens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.